Latest Breaking News On - Edgewise therapeutics - Page 3 : comparemela.com

Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 - GSK (NYSE:GSK)

Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 - GSK (NYSE:GSK)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Bobak azamianDarlene morrisTarsus pharmaceuticalsZai lab limitedTarsus pharmaceuticals incEdgewise therapeutics incZai labChief executive officerEdgewise therapeuticsBeyond meat and

Edgewise Therapeutics (EWTX) Appoints Arlene Morris to its Board of Directors

Edgewise Therapeutics (EWTX) Appoints Arlene Morris to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Darlene morrisKevin kochSyndax pharmaceuticalsEdgewise therapeutics incEdgewise therapeuticsChief executiveChief executive officerWillow advisorsClearview projectsCoulter pharmaceuticalCogent biosciencesPalatin technologies

Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors

Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Darlene morrisKevin kochEdgewise therapeutics incSyndax pharmaceuticalsEdgewise therapeuticsChief executiveChief executive officerWillow advisorsClearview projectsCoulter pharmaceuticalCogent biosciencesPalatin technologies

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year High at $21 51

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year High at $21 51
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerBehrad derakhshanJohnr mooreSg americas securitiesEdgewise therapeutics incCorton capital incSecurities exchange commissionChina universal asset management coRoyal bankEdgewise therapeuticsGet free reportGeneral counsel johnExchange commissionUniversal asset managementFire capitalEdgewise therapeutics daily

Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)

Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced the dosing of the first patient in the Phase 2 CIRRUS-HCM trial of EDG-7500. EDG-7500 is a novel.

Marc semigranKevin kochSecurities exchangeEdgewise therapeutics incExchange commissionEdgewise therapeuticsChief development officerChief executive officerSecurities actSecurities exchange act